Kestra Private Wealth Services’s AbCellera Biologics ABCL Stock Holding History

Kestra Private Wealth Services’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91.8K	Sell	11,700 -1,000	-8%	-$4.89K	﹤0.01%	1747
2026 Q1	$44.3K	Hold	12,700	–	–	﹤0.01%	1715
2025 Q4	$43.4K	Buy	12,700 +900	+8%	+$4.02K	﹤0.01%	1687
2025 Q3	$59.4K	Sell	11,800 -800	-6%	-$3.53K	﹤0.01%	1629
2025 Q2	$43.2K	Hold	12,600	–	–	﹤0.01%	1579
2025 Q1	$28.1K	Hold	12,600	–	–	﹤0.01%	1487
2024 Q4	$36.9K	Buy	12,600 +1,600	+15%	+$4.46K	﹤0.01%	1401
2024 Q3	$28.6K	Buy	+11,000	New	+$30.5K	﹤0.01%	1344

Other funds holding ABCL

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

CMF

Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

DRP

Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

HOWA

Heritage Oak Wealth Advisors Santa Rosa Beach, Florida $340M AUM 29.73% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.37B AUM 28.49% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Kestra Private Wealth Services's ABCL Position: Q2 2026 in Review

Kestra Private Wealth Services reduced its AbCellera Biologics (ABCL) stake by 7.9% in Q2 2026, selling an estimated $4.89K and leaving 11,700 shares worth $91.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

Kestra Private Wealth Services first reported a position in ABCL in Q3 2024 and has held it in 8 quarters since. 31 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

Kestra Private Wealth Services held 11,700 shares of AbCellera Biologics worth $91.8K as of Q2 2026.
Kestra Private Wealth Services sold 1,000 AbCellera Biologics shares in Q2 2026, an estimated $4.89K.
AbCellera Biologics made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1747 holding.
Kestra Private Wealth Services first reported a position in AbCellera Biologics in Q3 2024 and has held it in 8 quarters since.
31 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.